CHRISTOPHER VENTURA: Open Payments
NPI 1417634528 · NORTH BABYLON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 30 payments from 18 companies in 2025. Trend: 2023 $251 · 2024 $800 · 2025 $959
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $211 |
| Novo Nordisk Inc | 4 | $167 |
| Amgen Inc. | 1 | $125 |
| ABBVIE INC. | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Xeris Pharmaceuticals, Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Neurelis, Inc. | 1 | $25 |
Products named: Ozempic, REPATHA, BREZTRI, FARXIGA, REXULTI, RECORLEV, VERQUVO, GEMTESA.
Industry payments across NY — which companies pay providers there.
